Results for tag: "Islet Cell Carcinoma Drug"

Islet Cell Carcinoma (ICC) is a rare form of cancer that affects the islet cells of the pancreas. It is a type of neuroendocrine tumor, which is a type of cancer that develops from cells that release hormones into the bloodstream. Treatment for ICC typically involves a combination of surgery, chemotherapy, and radiation therapy. Oncology drugs are used to treat cancer, including ICC. These drugs can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the side effects of other treatments. Commonly used oncology drugs for ICC include somatostatin analogs, interferon-alpha, and chemotherapy drugs. The Islet Cell Carcinoma Drug market is a rapidly growing segment of the oncology drug market. As the incidence of ICC increases, the demand for effective treatments is also increasing. Companies in this market include Novartis, Pfizer, and Merck. Show Less Read more